Recently, a team led by Chief Physician Chen Yicheng from the Department of Urology at Sir Run Run Shaw Hospital of Zhejiang University, together with a multidisciplinary team (MDT) including Nuclear Medicine, Medical Oncology, and Radiology, successfully administered Lutetium-177 Tixivapitide Injection (radioligand therapy) to a 70-something patient with prostate cancer.